Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

UnitedHealthcare, Humana, CVS join new value-based prescription model

The participants in CMS’s Medicare Part D model designed to incentivize medication adherence programs will include some of the largest insurers in the U.S.

BioBridge Global-led biotech team awarded $7.8 million Army contract

SAN ANTONIO, Oct. 3, 2016 /PRNewswire-USNewswire/ -- A four-organization biotech group led by San Antonio-based nonprofit BioBridge Global (BBG) has been awarded a $7.8 million contract from the Medical Technology Enterprise Consortium (MTEC).

CDC: Physicians should confirm patients’ penicillin allergies

New research from the U.S. Center for Disease Control and Prevention (CDC) points to evidence that many patients who claim they have a penicillin allergy may actually not have one.

CDC updates recommendations on avoiding pregnancy after Zika

As researchers begin to understand more about the Zika virus, the CDC is updating its recommendations for the public based on new information. On Sept. 30, the agency changed its guidelines to recommend couples wait at least six months from the last possible exposure to Zika before trying to become pregnant. 

House Republicans to CMS: Bundled payments shouldn’t be mandatory

Some 179 members of Congress have accused CMS of overstepping its authority in making bundled payment models, like one for cardiac episodes, mandatory without getting their approval.

California enacts new laws on nurse staffing, balance billing

A flurry of legislative activity in California in September included several new laws that will impact healthcare in the state.

Research thwarted by unreliable antibodies

More than 100 scientists met in California to find a solution to the increasingly research-thwarting problem of unreliable antibodies, according to NPR. 

3 things to know about CMS’s final long-term care rule

CMS has finalized its rule updating requirements for long-term care facilities participating in Medicare and Medicaid, the first such update since 1991.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.